These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3322137)

  • 1. Ocular side effects of systemic steroid therapy in renal transplant patients.
    Debnath SC; Abomelha MS; Jawdat M; Chang R; Al-Khader AA
    Ann Ophthalmol; 1987 Nov; 19(11):435-7. PubMed ID: 3322137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cataract in renal transplantation recipients with combination ciclosporin treatment.
    Nishimoto K; Sasaki K; Yamamura T; Ishikawa I; Shinoda A
    Lens Eye Toxic Res; 1992; 9(3-4):455-67. PubMed ID: 1301797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A1 and steroid-induced cataracts in renal transplant patients.
    Kollarits CR; Swann ER; Shapiro RS; Gillespie CM; Shealy TA
    Ann Ophthalmol; 1982 Dec; 14(12):1116-8. PubMed ID: 6762131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of rejection following heart transplantation using oral steroid medication].
    Wahlers T; Frimpong K; Schäfers HJ; Fieguth HJ; Jurmann M; Herrmann G; Kemnitz J; Haverich A
    Dtsch Med Wochenschr; 1987 Nov; 112(47):1816-8. PubMed ID: 3315549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity.
    Klaus G; Jeck N; Konrad M; Förster B; Soergel M
    Clin Nephrol; 2001 Dec; 56(6):S37-42. PubMed ID: 11770812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular complications in renal transplant patients.
    Matsunami C; Hilton AF; Dyer JA; Rumbach OW; Hardie IR
    Aust N Z J Ophthalmol; 1994 Feb; 22(1):53-7. PubMed ID: 8037915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular complications in renal transplant recipients.
    Pavlin CR; deVeber GA; Cook GT; Chisholm LD
    Can Med Assoc J; 1977 Aug; 117(4):360-2. PubMed ID: 329970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of steroids in combination with other pharmacologic immunosuppressive agents.
    Salaman JR
    J Heart Transplant; 1986; 5(4):304-6. PubMed ID: 3305822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimising the risks of treating acute allograft rejection.
    Siegel RR; Aquino HC; Luke RG; Schmidt R
    Proc Eur Dial Transplant Assoc; 1975; 11():351-6. PubMed ID: 1105556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior subcapsular cataracts induced by topical corticosteroids following keratoplasty for keratoconus.
    Donshik PC; Cavanaugh HD; Boruchoff SA; Dohlman CH
    Ann Ophthalmol; 1981 Jan; 13(1):29-32. PubMed ID: 7018341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizures and blindness following intravenous pulse methylprednisolone in a renal transplant patient.
    el-Dahr S; Chevalier RL; Gomez RA; Campbell FG
    Int J Pediatr Nephrol; 1987; 8(2):87-90. PubMed ID: 3308730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid steroid discontinuation for pediatric renal transplantation: a single center experience.
    Lau KK; Haddad MN; Berg GM; Perez RV; Butani L
    Pediatr Transplant; 2007 Aug; 11(5):504-10. PubMed ID: 17631018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-induced glaucoma and cataract in renal transplant recipients.
    Ticho U; Durst A; Licht A; Berkowitz S
    Isr J Med Sci; 1977 Sep; 13(9):871-4. PubMed ID: 336581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular complications after renal transplantation.
    Pfefferman R; Gombos GM; Kountz SL
    Ann Ophthalmol; 1977 Apr; 9(4):467-70, 473. PubMed ID: 326125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular complications amongst renal transplant patients.
    Chugh KS; Singhal PC; Yadav RV; Tewari SC; Nath IV; Kaul RK; Sahariah S
    J Assoc Physicians India; 1979 Jan; 27(1):27-31. PubMed ID: 389920
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Oya H; Nakatsuka H; Kobayashi T; Watanabe T; Kameyama H; Hatakeyama K
    Hepatogastroenterology; 2003; 50(51):601-6. PubMed ID: 12828042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+/CD8+ lymphocyte patterns in renal transplant recipients receiving chronic methylprednisolone.
    Tornatore KM; Reed K; Venuto RC
    J Med; 1993; 24(2-3):98-112. PubMed ID: 8105017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.